1
|
Román GC: Vascular dementia may be the
most common form of dementia in the elderly. J Neurol Sci.
203–204:7–10. 2002. View Article : Google Scholar
|
2
|
Iemolo F, Duro G, Rizzo C, Castiglia L,
Hachinski V and Caruso C: Pathophysiology of vascular dementia.
Immun Ageing. 6:132009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Zekry D, Herrmann FR, Graf CE, Giannelli
S, Michel JP, Gold G and Krause KH: Mild cognitive impairment,
degenerative and vascular dementia as predictors of intra-hospital,
short- and long-term mortality in the oldest old. Aging Clin Exp
Res. 23:60–66. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ekonomou A, Ballard CG, Pathmanaban ON,
Perry RH, Perry EK, Kalaria RN and Minger SL: Increased neural
progenitors in vascular dementia. Neurobiol Aging. 32:2152–2161.
2011. View Article : Google Scholar
|
5
|
Poels MM, Ikram MA, van der Lugt A, Hofman
A, Niessen WJ, Krestin GP, Breteler MM and Vernooij MW: Cerebral
micro-bleeds are associated with worse cognitive function: The
Rotterdam Scan Study. Neurology. 78:326–333. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Wu CX, Liu R, Gao M, Zhao G, Wu S, Wu CF
and Du GH: Pinocembrin protects brain against ischemia/reperfusion
injury by attenuating endoplasmic reticulum stress induced
apoptosis. Neurosci Lett. 546:57–62. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Nishio K, Ihara M, Yamasaki N, Kalaria RN,
Maki T, Fujita Y, Ito H, Oishi N, Fukuyama H, Miyakawa T, et al: A
mouse model characterizing features of vascular dementia with
hippocampal atrophy. Stroke. 41:1278–1284. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Chen CH, Jiang Z, Yan JH, Yang L, Wang K,
Chen YY, Han JY, Zhang JH and Zhou CM: The involvement of
programmed cell death 5 (PDCD5) in the regulation of apoptosis in
cerebral ischemia/reperfusion injury. CNS Neurosci Ther.
19:566–576. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Eberspächer E, Werner C, Engelhard K, Pape
M, Gelb A, Hutzler P, Henke J and Kochs E: The effect of
hypothermia on the expression of the apoptosis-regulating protein
Bax after incomplete cerebral ischemia and reperfusion in rats. J
Neurosurg Anesthesiol. 15:200–208. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bernabeu R, Bevilaqua L, Ardenghi P,
Bromberg E, Schmitz P, Bianchin M, Izquierdo I and Medina JH:
Involvement of hippocampal cAMP/cAMP-dependent protein kinase
signaling pathways in a late memory consolidation phase of
aversively motivated learning in rats. Proc Natl Acad Sci USA.
94:7041–7046. 1997. View Article : Google Scholar : PubMed/NCBI
|
11
|
Abel T, Nguyen PV, Barad M, Deuel TA,
Kandel ER and Bourtchouladze R: Genetic demonstration of a role for
PKA in the late phase of LTP and in hippocampus-based long-term
memory. Cell. 88:615–626. 1997. View Article : Google Scholar : PubMed/NCBI
|
12
|
Hagiwara M, Brindle P, Harootunian A,
Armstrong R, Rivier J, Vale W, Tsien R and Montminy MR: Coupling of
hormonal stimulation and transcription via the cyclic AMP-reponsive
factor CREB is rate limited by nucluear entry of protein kinase A.
Mol Cell Biol. 13:4852–4859. 1993.PubMed/NCBI
|
13
|
Chutae DL, Villiger JW and Kirton NF:
Testing cyclic AMP mediation of memory: Reversal of
alpha-methyl-p-tyrosine-induced amnesia. Psychopharmacology (Berl).
74:129–131. 1981. View Article : Google Scholar
|
14
|
Zhao WQ, Polya GM, Wang BH, Gibbs ME,
Sedman GL and Ng KT: Inhibitors of cAMP-dependent protein kinase
impair long-term memory formation in day-old chicks. Neurobiol
Learn Mem. 64:106–118. 1995. View Article : Google Scholar : PubMed/NCBI
|
15
|
Guzowski JF and McGaugh JL: Antisense
oligodeoxynu-cleotide-mediated disruption of hippocampal cAMP
response element binding protein levels impairs consolidation of
memory for water maze training. Proc Natl Acad Sci USA.
94:2693–2698. 1997. View Article : Google Scholar
|
16
|
Nagakura A, Niimura M and Takeo S: Effects
of a phosphodiesterase IV inhibitor rolipram on microsphere
embolism-induced defects in memory function and cerebral cyclic AMP
signal transduction system in rats. Br J Pharmacol. 135:1783–1793.
2002. View Article : Google Scholar : PubMed/NCBI
|
17
|
Takeo S, Niimura M, Miyake-Takagi K,
Nagakura A, Fukatsu T, Ando T, Takagi N, Tanonaka K and Hara J: A
possible mechanism for improvement by a cognition-enhancer
nefiracetam of spatial memory function and cAMP-mediated signal
transduction system in sustained cerebral ischaemia in rats. Br J
Pharmacol. 138:642–654. 2003. View Article : Google Scholar : PubMed/NCBI
|
18
|
Li TW, Tang N and Zhao QS: Clinical
observation of Yifei Xuanfei Jiangzhuo Formula treated vascular
dementia. Guangxi J Trad Chin Med. 37:105–107. 2014.In Chinese.
|
19
|
Leung KS, Bian ZX, Moher D, Dagenais S, Li
YP, Liu L, Wu TX and Miao JX: Improving the quality of randomized
controlled trials in Chinese herbal medicine, part III: Quality
control of Chinese herbal medicine used in randomized controlled
trials. J Chin Integr Med. 4:225–232. 2006. View Article : Google Scholar
|
20
|
Alipanahzadeh H, Soleimani M, Soleimani
Asl S, Pourheydar B, Nikkhah A and Mehdizadeh M: Transforming
growth factor-α improves memory impairment and neurogenesis
following ischemia reperfusion. Cell J. 16:315–324. 2014.PubMed/NCBI
|
21
|
Wu YY, Wu WY, Gong HL, Li WZ and Yin YY:
Astragalosides attenuate learning and memory impairment in rats
following ischemia-reperfusion injury. Mol Med Rep. 9:1319–1324.
2014.PubMed/NCBI
|
22
|
Langdon KD, Granter-Button S, Harley CW,
Moody-Corbett F, Peeling J and Corbett D: Cognitive rehabilitation
reduces cognitive impairment and normalizes hippocampal CA1
architecture in a rat model of vascular dementia. J Cereb Blood
Flow Metab. 33:872–879. 2013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Li H and Xin X: Nitrogen dioxide (NO(2))
pollution as a potential risk factor for developing vascular
dementia and its synaptic mechanisms. Chemosphere. 92:52–58. 2013.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Zhang S, Qi Y, Xu Y, Han X, Peng J, Liu K
and Sun CK: Protective effect of flavonoid-rich extract from Rosa
laevigata Michx on cerebral ischemia-reperfusion injury through
suppression of apoptosis and inflammation. Neurochem Int.
63:522–532. 2013. View Article : Google Scholar : PubMed/NCBI
|
25
|
Feng XT, Wang TZ, Chen Y, Liu JB, Liu Y
and Wang WJ: Pollen Typhae total flavone improves insulin-induced
glucose uptake through the β-arrestin-2-mediated signaling in C2C12
myotubes. Int J Mol Med. 30:914–922. 2012.PubMed/NCBI
|
26
|
Zekry D: Is it possible to treat vascular
dementia? Front Neurol Neurosci. 24:95–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
27
|
Baskys A and Hou AC: Vascular dementia:
Pharmacological treatment approaches and perspectives. Clin Interv
Aging. 2:327–335. 2007.PubMed/NCBI
|
28
|
Malykh AG and Sadaie MR: Piracetam and
piracetam-like drugs: From basic science to novel clinical
applications to CNS disorders. Drugs. 70:287–312. 2010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Hartman RE, Lee JM, Zipfel GJ and Wozniak
DF: Characterizing learning deficits and hippocampal neuron loss
following transient global cerebral ischemia in rats. Brain Res.
1043:48–56. 2005. View Article : Google Scholar : PubMed/NCBI
|
30
|
Xing SH, Zhu CX, Zhang R and An L:
Huperzine a in the treatment of Alzheimer's disease and vascular
dementia: A meta-analysis. Evid Based Complement Alternat Med.
2014:3639852014. View Article : Google Scholar : PubMed/NCBI
|
31
|
He Z, Liao Y, Zheng M, Zeng FD and Guo LJ:
Piracetam improves cognitive deficits caused by chronic cerebral
hypoperfusion in rats. Cell Mol Neurobiol. 28:613–627. 2008.
View Article : Google Scholar
|
32
|
Lee JY, Lee HE, Kang SR, Choi HY, Ryu JH
and Yune TY: Fluoxetine inhibits transient global ischemia-induced
hippo-campal neuronal death and memory impairment by preventing
blood-brain barrier disruption. Neuropharmacology. 79:161–171.
2014. View Article : Google Scholar
|
33
|
Carson DA and Ribeiro JM: Apoptosis and
disease. Lancet. 341:1251–1254. 1993. View Article : Google Scholar : PubMed/NCBI
|
34
|
O'Reilly LA and Strasser A: Apoptosis and
autoimmune disease. Inflamm Res. 48:5–21. 1999. View Article : Google Scholar : PubMed/NCBI
|
35
|
Fang M, Li J, Tiu SC, Zhang L, Wang M and
Yew DT: N-methyl-D-aspartate receptor and apoptosis in Alzheimer's
disease and multiinfarct dementia. J Neurosci Res. 81:269–274.
2005. View Article : Google Scholar : PubMed/NCBI
|
36
|
Espinosa-García C, Vigueras-Villaseñor RM,
Rojas-Castañeda JC, Aguilar-Hernández A, Monfil T, Cervantes M and
Moralí G: Post-ischemic administration of progesterone reduces
caspase-3 activation and DNA fragmentation in the hippocampus
following global cerebral ischemia. Neurosci Lett. 550:98–103.
2013. View Article : Google Scholar : PubMed/NCBI
|
37
|
Zhou J and Tang XC: Huperzine A attenuates
apoptosis and mitochondria-dependent caspase-3 in rat cortical
neurons. FEBS Lett. 526:21–25. 2002. View Article : Google Scholar : PubMed/NCBI
|
38
|
Gabryel B, Adamek M, Pudełko A, Małecki A
and Trzeciak HI: Piracetam and vinpocetine exert cytoprotective
activity and prevent apoptosis of astrocytes in vitro in hypoxia
and reoxy-genation. Neurotoxicology. 23:19–31. 2002. View Article : Google Scholar : PubMed/NCBI
|
39
|
Murphy KM, Ranganathan V, Farnsworth ML,
Kavallaris M and Lock RB: Bcl-2 inhibits Bax translocation from
cytosol to mitochondria during drug-induced apoptosis of human
tumor cells. Cell Death Differ. 7:102–111. 2000. View Article : Google Scholar : PubMed/NCBI
|
40
|
Jürgensmeier JM, Xie Z, Deveraux Q,
Ellerby L, Bredesen D and Reed JC: Bax directly induces release of
cytochrome C from isolated mitochondria. Proc Natl Acad Sci USA.
95:4997–5002. 1998. View Article : Google Scholar : PubMed/NCBI
|
41
|
Narita M, Shimizu S, Ito T, Chittenden T,
Lutz RJ, Matsuda H and Tsujimoto Y: Bax interacts with the
permeability transition pore to induce permeability transition and
cytochrome c release in isolated mitochondria. Proc Natl Acad Sci
USA. 95:14681–14686. 1998. View Article : Google Scholar : PubMed/NCBI
|
42
|
Shaulian E and Karin M: AP-1 as a
regulator of cell life and death. Nat Cell Biol. 4:E131–E136. 2002.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Yang S, Zhou G, Liu H, Zhang B, Li J, Cui
R and Du Y: Protective effects of p38 MAPK inhibitor SB202190
against hippocampal apoptosis and spatial learning and memory
deficits in a rat model of vascular dementia. Biomed Res Int.
2013:2157982013. View Article : Google Scholar
|
44
|
Sun ZK, Ma XR, Jia YJ, Liu YR, Zhang JW
and Zhang BA: Effects of resveratrol on apoptosis in a rat model of
vascular dementia. Exp Ther Med. 7:843–848. 2014.PubMed/NCBI
|
45
|
Zhang TL, Fu JL, Geng Z, Yang JJ and Sun
XJ: The neuroprotective effect of losartan through inhibiting
AT1/ASK1/MKK4/JNK3 pathway following cerebral I/R in rat
hippocampal CA1 region. CNS Neurosci Ther. 18:981–987. 2012.
View Article : Google Scholar : PubMed/NCBI
|
46
|
Wang R, Zhang HY and Tang XC: Huperzine A
attenuates cognitive dysfunction and neuronal degeneration caused
by beta-amyloid protein-(1-40) in rat. Eur J Pharmacol.
421:149–156. 2001. View Article : Google Scholar : PubMed/NCBI
|
47
|
He Z, Hu M, Zha YH, Li ZC, Zhao B, Yu LL,
Yu M and Qian Y: Piracetam ameliorated oxygen and glucose
deprivation-induced injury in rat cortical neurons via inhibition
of oxidative stress, excitatory amino acids release and P53/Bax.
Cell Mol Neurobiol. 34:539–547. 2014. View Article : Google Scholar : PubMed/NCBI
|
48
|
Gonzalez GA and Montminy MR: Cyclic AMP
stimulates somatostatin gene transcription by phosphorylation of
CREB at serine 133. Cell. 59:675–680. 1989. View Article : Google Scholar : PubMed/NCBI
|
49
|
Weth G: The influence of piracetam on the
cyclic adenosine monophosphate (cAMP) concentration in the brain
and colon of guinea pigs. Arzneimittelforschung. 33:812–814.
1983.PubMed/NCBI
|
50
|
Yao H, Gu LJ and Guo JY: Study on effect
of astragali radix polysaccharides in improving learning and memory
functions in aged rats and its mechanism. China J Chin Mater Med.
39:2071–2075. 2014.In Chinese.
|